Home Antibodies Monoclonal Antibodies Page 3

Monoclonal Antibodies

Latest
Monoclonal Antibodies

Celgene Scraps $2.6B Deal, Licenses Jounce Antibody in Restructured Cancer Collaboration

Monoclonal Antibodies

BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B...

Agilent eBook Cover
Monoclonal Antibodies

End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization

Neuron
Monoclonal Antibodies

Genentech’s Crenezumab Fails Two Phase III Trials in Alzheimer’s

Monoclonal Antibodies

BioNTech to Acquire MAB Discovery’s Antibody Generation Unit, Building on Six-Year...

ProteoGenix lab
Monoclonal Antibodies

What Makes a Successful Therapeutic Monoclonal Antibody?

Ten days after being treated with an intestine-damaging drug
Monoclonal Antibodies

Peaceable Gut Microbiota Express Symbiosis-Promoting Factors in Response to IgA

An illustration of Visterra's Hierotope® platform
Monoclonal Antibodies

Otsuka to Acquire Visterra for $430M, Adding to Its Pipeline and...

Arsanis has ended a Phase II trial for ASN100
Monoclonal Antibodies

Arsanis Halts Phase II Trial of Pneumonia Candidate ASN100

Lonza will increase its mid-scale biologics manufacturing capacity as part of an expansion of its Portsmouth
Monoclonal Antibodies

Lonza to Expand Mid-Scale Biologics Manufacturing Capacity in Portsmouth, NH

1234...33Page 3 of 33

Recently Featured

Copyright © 2021 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up